Physician Assistant in Brewster, NY Accepting Medicare

4 Physician Assistant nurses found. Showing 1 - 4

Joseph Thomas Medwid, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 48 Farrell Dr, Brewster, NY 10509 Phone: 845-494-8296

Daniel Stephens, P.A. Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 2050 Route 22, Brewster, NY 10509 Phone: 845-279-2323    Fax: 845-278-2115

Sean C Osullivan, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Clock Tower Cmns, Northern Medical Group, Pllc, Brewster, NY 10509 Phone: 845-592-4915    Fax: 845-592-4914

Lisa Christine Boston, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 155 Main St, Brewster, NY 10509 Phone: 845-279-6999

News Archive

Boehringer Ingelheim disappointed with FDA Advisory Committee recommendations on flibanserin NDA for HSDD

The Reproductive Health Drugs Advisory Committee met today to discuss the new drug application (NDA) for flibanserin 100 mg as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women. The advisory committee was convened by and makes recommendations to the U.S. Food and Drug Administration (FDA). The FDA will consider the committee's advice as part of its final assessment of the NDA.

Researchers develop a rapid method to assess thirdhand smoke contaminants in household fabrics

A study led by scientists at the University of California, Riverside, has found chemicals in thirdhand smoke, or THS, get extracted more readily from household fabrics in a humid environment than in a dry one.

Study shows how Chlamydia bacteria enter human cells

Chlamydia are bacteria that can infect human and animal cells. Human health is particularly affected by Chlamydia pneumoniae (Cpn) and Chlamydia trachomatis.

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics, Inc.), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen specific diseases, announced positive topline results from the first Phase 2a study of SYN-004, the Company's candidate designed to protect the gut microbiome from the unintended effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD).

Bern study sheds light on the brain mechanism of arousal

Scientists from Bern have discovered a mechanism which is responsible for the rapid arousal from sleep and anesthesia in the brain. The results of their study suggest new strategies for the medical treatment of sleep disorders and recovery of consciousness in vegetative states.

Read more Medical News

› Verified 9 days ago